Swing Therapeutics

company

About

Swing Therapeutics provides digital therapeutics for people with chronic conditions.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$10.30M
Industries
Biotechnology,Therapeutics
Founded date
Jun 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regain control of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10.30M
Swing Therapeutics has raised a total of $10.30M in funding over 2 rounds. Their latest funding was raised on Jun 16, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 16, 2022 Series A $10.30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Swing Therapeutics is funded by 1 investors. Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Series A